Cross Shawn 4
4 · Pacira BioSciences, Inc. · Filed Nov 5, 2024
Insider Transaction Report
Form 4
Cross Shawn
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-11-04+200,000→ 200,000 totalExercise: $16.45Exp: 2034-11-04→ Common Stock (200,000 underlying) - Award
Common Stock
2024-11-01+75,000→ 75,000 total
Footnotes (2)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on November 1, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.